Alkem Laboratories Limited has informed the Exchange regarding a press release dated September 25, 2023, titled "ALKEM enters into a co-development and license agreement with Biosergen AB".
Press Release Sep 25 2023
Filed with NSE ·
6ix hasn’t read this filing yet.
Alkem Laboratories Ltd. on 6ix
Earlier from Alkem Laboratories
- Press Release Apr 07 2023
- Alkem Subsidiary Enzene Launches Adalimumab Biosimilar In India
- Press Release Feb 23 2023
- Press Release Nov 10 2022
- Press Release Sep 15 2022
Later from Alkem Laboratories
- Press Release Dec 01 2023
- Press Release Feb 28 2024
- Press Release Mar 27 2024
- Press Release Jun 25 2024
- Press Release Sep 27 2024
Follow Alkem Laboratories into a list and get an email when it puts out news.
Follow Alkem Laboratories